Production (Stage)
Kits Eyecare Ltd.
KTYCF
$9.96
$0.363.75%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 122.86M | 116.19M | 107.43M | 99.96M | 94.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 122.86M | 116.19M | 107.43M | 99.96M | 94.65M |
| Cost of Revenue | 80.13M | 77.10M | 71.82M | 66.50M | 62.88M |
| Gross Profit | 42.73M | 39.09M | 35.61M | 33.46M | 31.77M |
| SG&A Expenses | 38.02M | 36.26M | 34.12M | 32.41M | 30.97M |
| Depreciation & Amortization | 632.10K | 858.00K | 1.08M | 1.31M | 1.52M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 118.78M | 114.21M | 107.01M | 100.22M | 95.38M |
| Operating Income | 4.07M | 1.97M | 419.60K | -257.80K | -725.70K |
| Income Before Tax | 4.74M | 3.19M | 22.60K | 246.40K | -1.12M |
| Income Tax Expenses | 1.44M | 960.00K | 102.70K | 65.50K | -283.80K |
| Earnings from Continuing Operations | 3.30 | 2.23 | -0.08 | 0.18 | -0.84 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.30M | 2.23M | -79.90K | 181.20K | -836.90K |
| EBIT | 4.07M | 1.97M | 419.60K | -257.80K | -725.70K |
| EBITDA | 5.53M | 3.58M | 2.06M | 1.51M | 1.17M |
| EPS Basic | 0.10 | 0.07 | 0.00 | 0.01 | -0.03 |
| Normalized Basic EPS | 0.09 | 0.06 | 0.00 | 0.00 | -0.02 |
| EPS Diluted | 0.10 | 0.07 | -0.01 | 0.00 | -0.04 |
| Normalized Diluted EPS | 0.09 | 0.06 | 0.00 | 0.00 | -0.02 |
| Average Basic Shares Outstanding | 126.47M | 126.06M | 125.90M | 125.74M | 125.66M |
| Average Diluted Shares Outstanding | 135.25M | 134.95M | 132.50M | 131.85M | 129.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |